Einrichtungen, die zum Universitätsklinikum Erlangen gehören

Advancements and challenges in CAR T cell therapy in autoimmune diseases (2024) Schett G, Müller F, Taubmann J, Mackensen A, Wang W, Furie RA, Gold R, et al. Journal article, Review article Biomarker-stratified first-line treatment of right-sided metastatic colon cancer with interdisciplinary collaboration in the IVOPAK II trial (2024) Vitali F, Merkel S, Schubart C, Schmid A, Eckstein M, Stöhr R, Kersting S, et al. Journal article Motivation and success factors in radiological research in Germany – results of a survey by the Methodology and Research Working Group of the German Radiological Society (2024) Wegner F, Heinrichs H, Stahlmann K, Molwitz I, Keller-Yamamura S, Kloeckner R, Barkhausen J, et al. Journal article Lang wirksames Wachstumshormon – eine neue Therapieoption für Kinder mit Wachstumshormonmangel: Status 2024 (2024) Dörr HG, Bettendorf M, Wölfle J, Saenger P, Ranke MB Journal article Modelling and Construction of Complex Shaped Polyvinyl Alcohol based Ultrasound Phantoms for Inverse Magnetomotive Ultrasound Imaging (2024) Heim C, Huber C, Ermert H, Ullmann I, Saleem T, Lyer S, Rupitsch SJ Conference contribution, Conference Contribution Magnetically Enhanced Ultrasound Strain Elastography to Visualize Magnetic Nanoparticles (2024) Huber C, Müller MS, Ermert H, Heim C, Rupitsch SJ, Ullmann I, Lyer S Conference contribution, Conference Contribution Airway management in a two-year-old child with a tongue tumor using video laryngoscope-assisted flexible bronchoscopic nasotracheal intubation (hybrid technique). (2024) Senger AS, Irouschek A, Weber M, Lutz R, Rompel O, Kesting MR, Schmidt J Journal article, Medical case study The mental health of first- and second-generation migrant vs. native healthcare workers during the COVID-19 pandemic: The VOICE survey of 7,187 employees in the German healthcare sector (2024) Herold R, Morawa E, Schug C, Geiser F, Beschoner P, Jerg-Bretzke L, Albus C, et al. Journal article Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD (2024) Akahoshi Y, Spyrou N, Weber D, Aguayo-Hiraldo P, Ayuk F, Chanswangphuwana C, Choe HK, et al. Journal article MoReLife – real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients (2024) Jilg S, Schwaab J, Sockel K, Crodel CC, Brückl V, Stegelmann F, Jentzsch M, et al. Journal article